Vitrolife AB (publ)

PINK:VTRLY USA Medical Devices
Market Cap
$2.44 Billion
Market Cap Rank
#6349 Global
#3579 in USA
Share Price
$18.00
Change (1 day)
+0.00%
52-Week Range
$18.00 - $18.00
All Time High
$58.88
About

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more

Vitrolife AB (publ) (VTRLY) - Total Liabilities

Latest total liabilities as of December 2025: $3.23 Billion USD

Based on the latest financial reports, Vitrolife AB (publ) (VTRLY) has total liabilities worth $3.23 Billion USD as of December 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Vitrolife AB (publ) - Total Liabilities Trend (2002–2025)

This chart illustrates how Vitrolife AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Vitrolife AB (publ) Competitors by Total Liabilities

The table below lists competitors of Vitrolife AB (publ) ranked by their total liabilities.

Company Country Total Liabilities
Shanghai Pret Composites
SHE:002324
China CN¥8.21 Billion
KSB SE & Co. KGaA
F:KSB3
Germany €1.48 Billion
Ola Electric Mobility Ltd
NSE:OLAELEC
India ₹53.08 Billion
SNKCF
PINK:SNKCF
USA $531.19 Billion
Zhuhai Orbita Control Eng
SHE:300053
China CN¥753.28 Million
Anhui Kouzi Distillery Co Ltd
SHG:603589
China CN¥2.11 Billion

Liability Composition Analysis (2002–2025)

This chart breaks down Vitrolife AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.40 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.41 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.29 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vitrolife AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vitrolife AB (publ) (2002–2025)

The table below shows the annual total liabilities of Vitrolife AB (publ) from 2002 to 2025.

Year Total Liabilities Change
2025-12-31 $3.23 Billion -15.14%
2024-12-31 $3.81 Billion +5.52%
2023-12-31 $3.61 Billion -5.38%
2022-12-31 $3.81 Billion -6.77%
2021-12-31 $4.09 Billion +1319.05%
2020-12-31 $288.07 Million -15.54%
2019-12-31 $341.06 Million +69.47%
2018-12-31 $201.25 Million +3.86%
2017-12-31 $193.78 Million -15.79%
2016-12-31 $230.11 Million +7.39%
2015-12-31 $214.27 Million -20.61%
2014-12-31 $269.91 Million +63.38%
2013-12-31 $165.21 Million -9.83%
2012-12-31 $183.22 Million +49.11%
2011-12-31 $122.88 Million +19.23%
2010-12-31 $103.06 Million +118.12%
2009-12-31 $47.25 Million -6.02%
2008-12-31 $50.27 Million +9.11%
2007-12-31 $46.08 Million -8.57%
2006-12-31 $50.40 Million +44.32%
2005-12-31 $34.92 Million -0.13%
2004-12-31 $34.96 Million -13.80%
2003-12-31 $40.56 Million -47.40%
2002-12-31 $77.11 Million --